Rujia Xie, Ph.D.

Senior Consultant


  • Joined Pharmetheus in 2024, actively working in client projects 
  • Expertise includes pharmacometrics in early and late phase projects in therapeutic areas such as infectious, neuropathic pain, inflammation & immunology, and pediatric drug development
  • Previously worked as Director in Pharmacometrics at Pfizer Singapore, where she led MIDD strategy, performed analyses, and supported filings for Pfizer global projects, as Head of Pharmacometrics at Pfizer China R&D, as Associate Director/Manager in Pharmacometrics at Pfizer, UK, and as Associate Professor/Assistant Professor/Teaching Assistant at China Pharmaceutical University, China
  • B.Sc in Pharmacy (1983) from Nanjing University of TCM, China, and Ph.D. in Pharmacokinetics (2000) from Uppsala University, Sweden
LinkedInGoogle Scholar